SGLT-2 Inhibitors Across the Complete Spectrum of Chronic Kidney Disease Aetiology: A Meta-Analysis of 21 Trials and 78,614 Participants Through May 2026

Authors: Abdulrahman Alanazi, Basmah Alanazi
Publication:
Published: Jun 2, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Reforming rape laws in Arab States: A comparative analysis of legal frameworks across 22 LAS countries

Unknown - Sep 2026

Read More
Blockchain Fee Policies: Quantity- vs Price-Control Design Across Protocols

Abdoulaye Ndiaye - Aug 2026

Read More
Targeting myeloid-specific immune checkpoint inhibitors as a vulnerability in highly aggressive triple-negative breast cancer

Silvia Redondo Garcia - Aug 2026

Read More
Spreading Out Across Expanding Idea Space

Ina Ganguli, Jeffery Lin et al. - Aug 2026

Read More
When self-reports and objective measures diverge across sleep and cognition: a protocol for a systematic review and dependence-aware meta-analysis

Lirong Wang, Peng Cheng - Aug 2026

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0